Last 12 months
Inside the activity.
5 purchase rows · 0 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 1 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 2 | 0 |
| Sep 2026 | 2 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 01, 2023 Filed Jun 2, 2023 20:38 UTC |
O'Brien Federica F.Director
|
GrantCommon Stock | 3,135 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-23-012779 · form4.xml · nonDerivative · entry 1 O'Brien Federica F. · CIK 0001140119 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,270 F1 · shares: These restricted stock units vest on the earlier of (a) June 1, 2024, (b) the next annual meeting of stockholders, or (c) the occurrence of a Change in Control (as defined in the Issuer's Amended and Restated 2019 Equity Incentive Plan), in each case subject to the Reporting Person's continued service through the applicable vesting date. Read SEC document |
| June 01, 2023 Filed Jun 2, 2023 16:38 UTC |
COLLERAN LISA NDirector
|
GrantStock Option (Right to Buy) · Derivative | 5,360 | $0.00 Strike: $10.34 | $0.00 |
DisclosureSEC source: 0001062993-23-012778 · form4.xml · derivative · entry 2 COLLERAN LISA N · CIK 0001212312 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,360 Underlying: Common Stock · 5,360 shares Expires 2033-06-01 F2 · derivative.exercise_date: The option vests on the earlier of (a) June 1, 2024, (b) the next annual meeting of stockholders, or (c) the occurrence of a Change in Control (as defined in the Issuer's Amended and Restated 2019 Equity Incentive Plan), in each case subject to the Reporting Person's continued service through the applicable vesting date. Read SEC document |
| June 01, 2023 Filed Jun 2, 2023 16:38 UTC |
COLLERAN LISA NDirector
|
GrantCommon Stock | 3,135 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-23-012778 · form4.xml · nonDerivative · entry 1 COLLERAN LISA N · CIK 0001212312 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,270 F1 · shares: These restricted stock units vest on the earlier of (a) June 1, 2024, (b) the next annual meeting of stockholders, or (c) the occurrence of a Change in Control (as defined in the Issuer's Amended and Restated 2019 Equity Incentive Plan), in each case subject to the Reporting Person's continued service through the applicable vesting date. Read SEC document |
| June 01, 2023 Filed Jun 2, 2023 16:37 UTC |
EVANS DOUGLAS GDirector
|
GrantStock Option (Right to Buy) · Derivative | 5,360 | $0.00 Strike: $10.34 | $0.00 |
DisclosureSEC source: 0001062993-23-012777 · form4.xml · derivative · entry 2 EVANS DOUGLAS G · CIK 0001225164 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,360 Underlying: Common Stock · 5,360 shares Expires 2033-06-01 F2 · derivative.exercise_date: The option vests on the earlier of (a) June 1, 2024, (b) the next annual meeting of stockholders, or (c) the occurrence of a Change in Control (as defined in the Issuer's Amended and Restated 2019 Equity Incentive Plan), in each case subject to the Reporting Person's continued service through the applicable vesting date. Read SEC document |
| June 01, 2023 Filed Jun 2, 2023 16:37 UTC |
EVANS DOUGLAS GDirector
|
GrantCommon Stock | 3,135 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-23-012777 · form4.xml · nonDerivative · entry 1 EVANS DOUGLAS G · CIK 0001225164 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,270 F1 · shares: These restricted stock units vest on the earlier of (a) June 1, 2024, (b) the next annual meeting of stockholders, or (c) the occurrence of a Change in Control (as defined in the Issuer's Amended and Restated 2019 Equity Incentive Plan), in each case subject to the Reporting Person's continued service through the applicable vesting date. Read SEC document |
| June 01, 2023 Filed Jun 2, 2023 16:36 UTC |
Burgess Vincent JDirector
|
GrantStock Option (Right to Buy) · Derivative | 5,360 | $0.00 Strike: $10.34 | $0.00 |
DisclosureSEC source: 0001062993-23-012774 · form4.xml · derivative · entry 2 Burgess Vincent J · CIK 0001365408 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,360 Underlying: Common Stock · 5,360 shares Expires 2033-06-01 F2 · derivative.exercise_date: The option vests on the earlier of (a) June 1, 2024, (b) the next annual meeting of stockholders, or (c) the occurrence of a Change in Control (as defined in the Issuer's Amended and Restated 2019 Equity Incentive Plan), in each case subject to the Reporting Person's continued service through the applicable vesting date. Read SEC document |
| June 01, 2023 Filed Jun 2, 2023 16:36 UTC |
Burgess Vincent JDirector
|
GrantCommon Stock | 3,135 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-23-012774 · form4.xml · nonDerivative · entry 1 Burgess Vincent J · CIK 0001365408 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,130 F1 · shares: These restricted stock units vest on the earlier of (a) June 1, 2024, (b) the next annual meeting of stockholders, or (c) the occurrence of a Change in Control (as defined in the Issuer's Amended and Restated 2019 Equity Incentive Plan), in each case subject to the Reporting Person's continued service through the applicable vesting date. Read SEC document |
| June 01, 2023 Filed Jun 2, 2023 20:37 UTC |
Azarbarzin KurtDirector
|
GrantStock Option (Right to Buy) · Derivative | 5,360 | $0.00 Strike: $10.34 | $0.00 |
DisclosureSEC source: 0001062993-23-012776 · form4.xml · derivative · entry 2 Azarbarzin Kurt · CIK 0001792303 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,360 Underlying: Common Stock · 5,360 shares Expires 2033-06-01 F2 · derivative.exercise_date: The option vests on the earlier of (a) June 1, 2024, (b) the next annual meeting of stockholders, or (c) the occurrence of a Change in Control (as defined in the Issuer's Amended and Restated 2019 Equity Incentive Plan), in each case subject to the Reporting Person's continued service through the applicable vesting date. Read SEC document |
| June 01, 2023 Filed Jun 2, 2023 20:37 UTC |
Azarbarzin KurtDirector
|
GrantCommon Stock | 3,135 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-23-012776 · form4.xml · nonDerivative · entry 1 Azarbarzin Kurt · CIK 0001792303 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,270 F1 · shares: These restricted stock units vest on the earlier of (a) June 1, 2024, (b) the next annual meeting of stockholders, or (c) the occurrence of a Change in Control (as defined in the Issuer's Amended and Restated 2019 Equity Incentive Plan), in each case subject to the Reporting Person's continued service through the applicable vesting date. Read SEC document |
| June 01, 2023 Filed Jun 2, 2023 20:36 UTC |
Nosenzo JohnDirector
|
GrantStock Option (Right to Buy) · Derivative | 5,360 | $0.00 Strike: $10.34 | $0.00 |
DisclosureSEC source: 0001062993-23-012775 · form4.xml · derivative · entry 2 Nosenzo John · CIK 0001835973 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,360 Underlying: Common Stock · 5,360 shares Expires 2033-06-01 F2 · derivative.exercise_date: The option vests on the earlier of (a) June 1, 2024, (b) the next annual meeting of stockholders, or (c) the occurrence of a Change in Control (as defined in the Issuer's Amended and Restated 2019 Equity Incentive Plan), in each case subject to the Reporting Person's continued service through the applicable vesting date. Read SEC document |
| June 01, 2023 Filed Jun 2, 2023 20:36 UTC |
Nosenzo JohnDirector
|
GrantCommon Stock | 3,135 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-23-012775 · form4.xml · nonDerivative · entry 1 Nosenzo John · CIK 0001835973 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,270 F1 · shares: These restricted stock units vest on the earlier of (a) June 1, 2024, (b) the next annual meeting of stockholders, or (c) the occurrence of a Change in Control (as defined in the Issuer's Amended and Restated 2019 Equity Incentive Plan), in each case subject to the Reporting Person's continued service through the applicable vesting date. Read SEC document |
| April 21, 2023 Filed Apr 21, 2023 21:08 UTC |
ORBIMED ADVISORS LLC10% owner
OrbiMed Capital GP IV LLC10% owner
|
SaleCommon Stock | 27,700 | $9.41 | $260,657.00 |
DisclosureSEC source: 0000947871-23-000484 · ownership.xml · nonDerivative · entry 3 ORBIMED ADVISORS LLC · CIK 0001055951 · 10% owner OrbiMed Capital GP IV LLC · CIK 0001502240 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See footnotes Disclosed balance after: 2,835,542 F1 · ownership.nature: These securities are held of record by OrbiMed Private Investments IV, LP ("OPI IV"). OrbiMed Capital GP IV LLC ("GP IV") is the general partner of OPI IV and OrbiMed Advisors LLC ("OrbiMed Advisors") is the managing member of GP IV. By virtue of such relationships, OrbiMed Advisors and GP IV may be deemed to have voting power and investment power over the securities held by OPI IV and, as a result, may be deemed to have beneficial ownership over such securities. OrbiMed Advisors exercises voting and investment power through a management committee comprised of Carl L. Gordon, Sven H. Borho, and W. Carter Neild, each of whom disclaims beneficial ownership of the securities held by OPI IV. F2 · ownership.nature: Each of OrbiMed Advisors and GP IV disclaims beneficial ownership of the securities reported herein for purposes of Rule 16a-1(a) under the Securities Exchange Act of 1934, as amended (the "Exchange Act"), except to the extent of its pecuniary interest therein, if any. This report shall not be deemed an admission that any such person or entity, including the Reporting Persons, is a beneficial owner of such securities for the purpose of Section 16 of the Exchange Act, or for any other purpose. Read SEC document |
| April 20, 2023 Filed Apr 21, 2023 21:08 UTC |
ORBIMED ADVISORS LLC10% owner
OrbiMed Capital GP IV LLC10% owner
|
SaleCommon Stock | 28,300 | $9.43 | $266,869.00 |
DisclosureSEC source: 0000947871-23-000484 · ownership.xml · nonDerivative · entry 2 ORBIMED ADVISORS LLC · CIK 0001055951 · 10% owner OrbiMed Capital GP IV LLC · CIK 0001502240 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See footnotes Disclosed balance after: 2,863,242 F1 · ownership.nature: These securities are held of record by OrbiMed Private Investments IV, LP ("OPI IV"). OrbiMed Capital GP IV LLC ("GP IV") is the general partner of OPI IV and OrbiMed Advisors LLC ("OrbiMed Advisors") is the managing member of GP IV. By virtue of such relationships, OrbiMed Advisors and GP IV may be deemed to have voting power and investment power over the securities held by OPI IV and, as a result, may be deemed to have beneficial ownership over such securities. OrbiMed Advisors exercises voting and investment power through a management committee comprised of Carl L. Gordon, Sven H. Borho, and W. Carter Neild, each of whom disclaims beneficial ownership of the securities held by OPI IV. F2 · ownership.nature: Each of OrbiMed Advisors and GP IV disclaims beneficial ownership of the securities reported herein for purposes of Rule 16a-1(a) under the Securities Exchange Act of 1934, as amended (the "Exchange Act"), except to the extent of its pecuniary interest therein, if any. This report shall not be deemed an admission that any such person or entity, including the Reporting Persons, is a beneficial owner of such securities for the purpose of Section 16 of the Exchange Act, or for any other purpose. Read SEC document |
| April 19, 2023 Filed Apr 21, 2023 21:08 UTC |
ORBIMED ADVISORS LLC10% owner
OrbiMed Capital GP IV LLC10% owner
|
SaleCommon Stock | 136,000 | $9.30 | $1,264,800.00 |
DisclosureSEC source: 0000947871-23-000484 · ownership.xml · nonDerivative · entry 1 ORBIMED ADVISORS LLC · CIK 0001055951 · 10% owner OrbiMed Capital GP IV LLC · CIK 0001502240 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See footnotes Disclosed balance after: 2,891,542 F1 · ownership.nature: These securities are held of record by OrbiMed Private Investments IV, LP ("OPI IV"). OrbiMed Capital GP IV LLC ("GP IV") is the general partner of OPI IV and OrbiMed Advisors LLC ("OrbiMed Advisors") is the managing member of GP IV. By virtue of such relationships, OrbiMed Advisors and GP IV may be deemed to have voting power and investment power over the securities held by OPI IV and, as a result, may be deemed to have beneficial ownership over such securities. OrbiMed Advisors exercises voting and investment power through a management committee comprised of Carl L. Gordon, Sven H. Borho, and W. Carter Neild, each of whom disclaims beneficial ownership of the securities held by OPI IV. F2 · ownership.nature: Each of OrbiMed Advisors and GP IV disclaims beneficial ownership of the securities reported herein for purposes of Rule 16a-1(a) under the Securities Exchange Act of 1934, as amended (the "Exchange Act"), except to the extent of its pecuniary interest therein, if any. This report shall not be deemed an admission that any such person or entity, including the Reporting Persons, is a beneficial owner of such securities for the purpose of Section 16 of the Exchange Act, or for any other purpose. Read SEC document |
| March 31, 2023 Filed Apr 4, 2023 18:01 UTC |
Talmo PaulChief Strategic Officer
|
Tax withholdingCommon Stock | 187 | $10.64 | $1,989.68 |
DisclosureSEC source: 0001062993-23-008665 · form4.xml · nonDerivative · entry 1 Talmo Paul · CIK 0001899089 · Chief Strategic Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 55,976 F1 · shares: Shares withheld by the Issuer to satisfy applicable withholding taxes upon vesting of restricted stock units. Read SEC document |
| March 31, 2023 Filed Apr 4, 2023 18:02 UTC |
Murphy Peter C.Chief Commercial Officer
|
Tax withholdingCommon Stock | 163 | $10.64 | $1,734.32 |
DisclosureSEC source: 0001062993-23-008666 · form4.xml · nonDerivative · entry 1 Murphy Peter C. · CIK 0001801542 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 37,987 F1 · shares: Shares withheld by the Issuer to satisfy applicable withholding taxes upon vesting of restricted stock units. Read SEC document |
| March 31, 2023 Filed Apr 4, 2023 18:03 UTC |
KOBLISH ANTONYDirector · Chief Executive Officer
|
Tax withholdingCommon Stock | 385 | $10.64 | $4,096.40 |
DisclosureSEC source: 0001062993-23-008668 · form4.xml · nonDerivative · entry 1 KOBLISH ANTONY · CIK 0001195881 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 292,634 F1 · shares: Shares withheld by the Issuer to satisfy applicable withholding taxes upon vesting of restricted stock units. Read SEC document |
| March 31, 2023 Filed Apr 4, 2023 22:03 UTC |
Smeykal MeganChief Accounting Officer · Controller
|
Tax withholdingCommon Stock | 96 | $10.64 | $1,021.44 |
DisclosureSEC source: 0001062993-23-008667 · form4.xml · nonDerivative · entry 1 Smeykal Megan · CIK 0001899973 · Chief Accounting Officer · Controller 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,431 F1 · shares: Shares withheld by the Issuer to satisfy applicable withholding taxes upon vesting of restricted stock units. Read SEC document |
| March 29, 2023 Filed Mar 31, 2023 16:32 UTC |
Burgess Vincent JDirector
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 4,860 | $0.00 Strike: $4.44 | $0.00 |
DisclosureSEC source: 0001062993-23-008208 · form4.xml · derivative · entry 2 Burgess Vincent J · CIK 0001365408 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,860 shares Expires 2023-04-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 29, 2023 Filed Mar 31, 2023 16:32 UTC |
Burgess Vincent JDirector
|
Exercise / conversionCommon Stock | 4,860 | $4.44 | $21,578.40 |
DisclosureSEC source: 0001062993-23-008208 · form4.xml · nonDerivative · entry 1 Burgess Vincent J · CIK 0001365408 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,995 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 24, 2023 Filed Feb 27, 2023 19:18 UTC |
Talmo PaulChief Strategic Officer
|
Tax withholdingCommon Stock | 1,032 | $11.03 | $11,382.96 |
DisclosureSEC source: 0001062993-23-005026 · form4.xml · nonDerivative · entry 3 Talmo Paul · CIK 0001899089 · Chief Strategic Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,163 F2 · shares: Shares withheld by the Issuer to satisfy applicable withholding taxes upon vesting of RSUs. Read SEC document |
| February 24, 2023 Filed Feb 27, 2023 19:19 UTC |
Murphy Peter C.Chief Commercial Officer
|
Tax withholdingCommon Stock | 940 | $11.03 | $10,368.20 |
DisclosureSEC source: 0001062993-23-005027 · form4.xml · nonDerivative · entry 3 Murphy Peter C. · CIK 0001801542 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,150 F2 · shares: Shares withheld by the Issuer to satisfy applicable withholding taxes upon vesting of RSUs. Read SEC document |
| February 24, 2023 Filed Feb 27, 2023 19:16 UTC |
KOBLISH ANTONYChief Executive Officer
|
Tax withholdingCommon Stock | 6,034 | $11.03 | $66,555.02 |
DisclosureSEC source: 0001062993-23-005025 · form4.xml · nonDerivative · entry 2 KOBLISH ANTONY · CIK 0001195881 · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 293,019 F2 · shares: Shares withheld by the Issuer to satisfy applicable withholding taxes upon vesting of RSUs. Read SEC document |
| February 24, 2023 Filed Feb 28, 2023 00:14 UTC |
Smeykal MeganChief Accounting Officer · Controller
|
Tax withholdingCommon Stock | 539 | $11.03 | $5,945.17 |
DisclosureSEC source: 0001062993-23-005024 · form4.xml · nonDerivative · entry 2 Smeykal Megan · CIK 0001899973 · Chief Accounting Officer · Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,527 F1 · shares: Shares withheld by the Issuer to satisfy applicable withholding taxes upon vesting of restricted stock units. Read SEC document |
| February 23, 2023 Filed Feb 27, 2023 19:18 UTC |
Talmo PaulChief Strategic Officer
|
GrantStock Option (Right to Buy) · Derivative | 26,400 | $0.00 Strike: $10.50 | $0.00 |
DisclosureSEC source: 0001062993-23-005026 · form4.xml · derivative · entry 4 Talmo Paul · CIK 0001899089 · Chief Strategic Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,400 Underlying: Common Stock · 26,400 shares Expires 2033-02-23 F3 · derivative.exercise_date: The option vests 25% on February 23, 2024, with the remaining 75% vesting in equal monthly installments on the last day of each of the 36 calendar months immediately following such date, subject to the Reporting Person's continued service through the applicable vesting dates. Read SEC document |
| February 23, 2023 Filed Feb 27, 2023 19:18 UTC |
Talmo PaulChief Strategic Officer
|
Tax withholdingCommon Stock | 1,067 | $10.50 | $11,203.50 |
DisclosureSEC source: 0001062993-23-005026 · form4.xml · nonDerivative · entry 2 Talmo Paul · CIK 0001899089 · Chief Strategic Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,195 F2 · shares: Shares withheld by the Issuer to satisfy applicable withholding taxes upon vesting of RSUs. Read SEC document |
| February 23, 2023 Filed Feb 27, 2023 19:18 UTC |
Talmo PaulChief Strategic Officer
|
GrantCommon Stock | 16,800 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-23-005026 · form4.xml · nonDerivative · entry 1 Talmo Paul · CIK 0001899089 · Chief Strategic Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 58,262 F1 · shares: These restricted stock units ("RSUs") will vest in four equal annual installments beginning on February 23, 2024, subject to the Reporting Person's continuous service through the applicable vesting dates. Read SEC document |
| February 23, 2023 Filed Feb 27, 2023 19:19 UTC |
Murphy Peter C.Chief Commercial Officer
|
GrantStock Option (Right to Buy) · Derivative | 26,400 | $0.00 Strike: $10.50 | $0.00 |
DisclosureSEC source: 0001062993-23-005027 · form4.xml · derivative · entry 4 Murphy Peter C. · CIK 0001801542 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,400 Underlying: Common Stock · 26,400 shares Expires 2033-02-23 F3 · derivative.exercise_date: The option vests 25% on February 23, 2024, with the remaining 75% vesting in equal monthly installments on the last day of each of the 36 calendar months immediately following such date, subject to the Reporting Person's continued service through the applicable vesting dates. Read SEC document |
| February 23, 2023 Filed Feb 27, 2023 19:19 UTC |
Murphy Peter C.Chief Commercial Officer
|
Tax withholdingCommon Stock | 906 | $10.50 | $9,513.00 |
DisclosureSEC source: 0001062993-23-005027 · form4.xml · nonDerivative · entry 2 Murphy Peter C. · CIK 0001801542 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,090 F2 · shares: Shares withheld by the Issuer to satisfy applicable withholding taxes upon vesting of RSUs. Read SEC document |
| February 23, 2023 Filed Feb 27, 2023 19:19 UTC |
Murphy Peter C.Chief Commercial Officer
|
GrantCommon Stock | 16,800 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-23-005027 · form4.xml · nonDerivative · entry 1 Murphy Peter C. · CIK 0001801542 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,996 F1 · shares: These restricted stock units ("RSUs") will vest in four equal annual installments beginning on February 23, 2024, subject to the Reporting Person's continuous service through the applicable vesting dates. Read SEC document |
| February 23, 2023 Filed Feb 27, 2023 19:16 UTC |
KOBLISH ANTONYChief Executive Officer
|
GrantStock Option (Right to Buy) · Derivative | 96,100 | $0.00 Strike: $10.50 | $0.00 |
DisclosureSEC source: 0001062993-23-005025 · form4.xml · derivative · entry 3 KOBLISH ANTONY · CIK 0001195881 · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 96,100 Underlying: Common Stock · 96,100 shares Expires 2033-02-23 F3 · derivative.exercise_date: The option vests 25% on February 23, 2024, with the remaining 75% vesting in equal monthly installments on the last day of each of the 36 calendar months immediately following such date, subject to the Reporting Person's continued service through the applicable vesting dates. Read SEC document |
| February 23, 2023 Filed Feb 27, 2023 19:16 UTC |
KOBLISH ANTONYChief Executive Officer
|
GrantCommon Stock | 61,200 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-23-005025 · form4.xml · nonDerivative · entry 1 KOBLISH ANTONY · CIK 0001195881 · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 299,053 F1 · shares: These restricted stock units ("RSUs") will vest in four equal annual installments beginning on February 23, 2024, subject to the Reporting Person's continuous service through the applicable vesting dates. Read SEC document |
| February 23, 2023 Filed Feb 28, 2023 00:20 UTC |
Cuca RobertoCOO and CFO
|
GrantStock Option (Right to Buy) · Derivative | 27,700 | $0.00 Strike: $10.50 | $0.00 |
DisclosureSEC source: 0001062993-23-005028 · form4.xml · derivative · entry 3 Cuca Roberto · CIK 0001591474 · COO and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,700 Underlying: Common Stock · 27,700 shares Expires 2033-02-23 F3 · derivative.exercise_date: The option vests 25% on February 23, 2024, with the remaining 75% vesting in equal monthly installments on the last day of each of the 36 calendar months immediately following such date, subject to the Reporting Person's continued service through the applicable vesting dates. Read SEC document |
| February 23, 2023 Filed Feb 28, 2023 00:20 UTC |
Cuca RobertoCOO and CFO
|
Tax withholdingCommon Stock | 1,300 | $10.50 | $13,650.00 |
DisclosureSEC source: 0001062993-23-005028 · form4.xml · nonDerivative · entry 2 Cuca Roberto · CIK 0001591474 · COO and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,292 F2 · shares: Shares withheld by the Issuer to satisfy applicable withholding taxes upon vesting of RSUs. Read SEC document |
| February 23, 2023 Filed Feb 28, 2023 00:20 UTC |
Cuca RobertoCOO and CFO
|
GrantCommon Stock | 17,700 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-23-005028 · form4.xml · nonDerivative · entry 1 Cuca Roberto · CIK 0001591474 · COO and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,592 F1 · shares: These restricted stock units ("RSUs") will vest in four equal annual installments beginning on February 23, 2024, subject to the Reporting Person's continuous service through the applicable vesting dates. Read SEC document |
| February 23, 2023 Filed Feb 28, 2023 00:14 UTC |
Smeykal MeganChief Accounting Officer · Controller
|
Tax withholdingCommon Stock | 423 | $10.50 | $4,441.50 |
DisclosureSEC source: 0001062993-23-005024 · form4.xml · nonDerivative · entry 1 Smeykal Megan · CIK 0001899973 · Chief Accounting Officer · Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,066 F1 · shares: Shares withheld by the Issuer to satisfy applicable withholding taxes upon vesting of restricted stock units. Read SEC document |
| February 21, 2023 Filed Feb 23, 2023 21:10 UTC |
Smeykal MeganChief Accounting Officer · Controller
|
GrantCommon Stock | 9,400 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-23-004533 · form4.xml · nonDerivative · entry 1 Smeykal Megan · CIK 0001899973 · Chief Accounting Officer · Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,489 F1 · shares: These restricted stock units will vest in four equal annual installments beginning on February 21, 2024, subject to the Reporting Person's continuous service through the applicable vesting dates. Read SEC document |
| November 03, 2022 Filed Nov 4, 2022 20:03 UTC |
Opaleye Management Inc.10% owner
|
PurchaseCommon Stock, par value $0.001 per share | 1,262 | $7.81 | $9,858.62 |
DisclosureSEC source: 0001493152-22-030666 · ownership.xml · nonDerivative · entry 2 Opaleye Management Inc. · CIK 0001595855 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Managed Account Disclosed balance after: 124,813 F3 · price: This transaction was executed in multiple trades at prices ranging from $7.76 to $7.85; the price reported above reflects the weighted average purchase price. The reporting person undertakes to provide upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased. F2 · ownership.nature: Securities owned by a separately managed account (the "Managed Account"). As the portfolio manager of the Managed Account, Opaleye may be deemed to beneficially own the securities owned directly by the Managed Account. Read SEC document |
| November 03, 2022 Filed Nov 4, 2022 20:03 UTC |
Opaleye Management Inc.10% owner
|
PurchaseCommon Stock, par value $0.001 per share | 19,000 | $7.81 | $148,426.10 |
DisclosureSEC source: 0001493152-22-030666 · ownership.xml · nonDerivative · entry 1 Opaleye Management Inc. · CIK 0001595855 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Opaleye, L.P. Disclosed balance after: 1,948,000 F3 · price: This transaction was executed in multiple trades at prices ranging from $7.76 to $7.85; the price reported above reflects the weighted average purchase price. The reporting person undertakes to provide upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased. F1 · ownership.nature: Represents securities owned directly by Opaleye, L.P. (the "Fund"). As the investment manager of the Fund, Opaleye Management Inc. may be deemed to beneficially own the securities owned directly by the Fund. Read SEC document |
| October 11, 2022 Filed Oct 11, 2022 23:29 UTC |
Opaleye Management Inc.10% owner
|
PurchaseCommon Stock, par value $0.001 per share | 1,000 | $8.00 | $8,000.00 |
DisclosureSEC source: 0001493152-22-028176 · ownership.xml · nonDerivative · entry 2 Opaleye Management Inc. · CIK 0001595855 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Managed Account Disclosed balance after: 123,551 F2 · ownership.nature: Securities owned by a separately managed account (the "Managed Account"). As the portfolio manager of the Managed Account, Opaleye may be deemed to beneficially own the securities owned directly by the Managed Account. Read SEC document |
| October 11, 2022 Filed Oct 11, 2022 23:29 UTC |
Opaleye Management Inc.10% owner
|
PurchaseCommon Stock, par value $0.001 per share | 15,000 | $8.00 | $120,000.00 |
DisclosureSEC source: 0001493152-22-028176 · ownership.xml · nonDerivative · entry 1 Opaleye Management Inc. · CIK 0001595855 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Opaleye, L.P. Disclosed balance after: 1,929,000 F1 · ownership.nature: Represents securities owned directly by Opaleye, L.P. (the "Fund"). As the investment manager of the Fund, Opaleye Management Inc. may be deemed to beneficially own the securities owned directly by the Fund. Read SEC document |
| September 23, 2022 Filed Sep 26, 2022 20:05 UTC |
Opaleye Management Inc.10% owner
|
PurchaseCommon Stock, par value $0.001 per share | 304 | $7.99 | $2,430.24 |
DisclosureSEC source: 0001493152-22-026798 · ownership.xml · nonDerivative · entry 2 Opaleye Management Inc. · CIK 0001595855 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Managed Account Disclosed balance after: 122,551 F3 · price: This transaction was executed in multiple trades at prices ranging from $7.9804 to $8.00; the price reported above reflects the weighted average purchase price. The reporting person undertakes to provide upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased. F2 · ownership.nature: Securities owned by a separately managed account (the "Managed Account"). As the portfolio manager of the Managed Account, Opaleye may be deemed to beneficially own the securities owned directly by the Managed Account. Read SEC document |
| September 23, 2022 Filed Sep 26, 2022 20:05 UTC |
Opaleye Management Inc.10% owner
|
PurchaseCommon Stock, par value $0.001 per share | 6,500 | $7.99 | $51,962.30 |
DisclosureSEC source: 0001493152-22-026798 · ownership.xml · nonDerivative · entry 1 Opaleye Management Inc. · CIK 0001595855 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Opaleye, L.P. Disclosed balance after: 1,914,000 F3 · price: This transaction was executed in multiple trades at prices ranging from $7.9804 to $8.00; the price reported above reflects the weighted average purchase price. The reporting person undertakes to provide upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased. F1 · ownership.nature: Represents securities owned directly by Opaleye, L.P. (the "Fund"). As the investment manager of the Fund, Opaleye Management Inc. may be deemed to beneficially own the securities owned directly by the Fund. Read SEC document |
| September 19, 2022 Filed Sep 19, 2022 23:27 UTC |
Opaleye Management Inc.10% owner
|
PurchaseCommon Stock, par value $0.001 per share | 1,000 | $8.09 | $8,088.00 |
DisclosureSEC source: 0001493152-22-026276 · ownership.xml · nonDerivative · entry 2 Opaleye Management Inc. · CIK 0001595855 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Managed Account Disclosed balance after: 122,247 F3 · price: This transaction was executed in multiple trades at prices ranging from $8.0873 to $8.09; the price reported above reflects the weighted average purchase price. The reporting person undertakes to provide upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased. F2 · ownership.nature: Securities owned by a separately managed account (the "Managed Account"). As the portfolio manager of the Managed Account, Opaleye may be deemed to beneficially own the securities owned directly by the Managed Account. Read SEC document |
| September 19, 2022 Filed Sep 19, 2022 23:27 UTC |
Opaleye Management Inc.10% owner
|
PurchaseCommon Stock, par value $0.001 per share | 17,000 | $8.09 | $137,496.00 |
DisclosureSEC source: 0001493152-22-026276 · ownership.xml · nonDerivative · entry 1 Opaleye Management Inc. · CIK 0001595855 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Opaleye, L.P. Disclosed balance after: 1,907,500 F3 · price: This transaction was executed in multiple trades at prices ranging from $8.0873 to $8.09; the price reported above reflects the weighted average purchase price. The reporting person undertakes to provide upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased. F1 · ownership.nature: Represents securities owned directly by Opaleye, L.P. (the "Fund"). As the investment manager of the Fund, Opaleye Management Inc. may be deemed to beneficially own the securities owned directly by the Fund. Read SEC document |
| September 16, 2022 Filed Sep 16, 2022 21:47 UTC |
Opaleye Management Inc.10% owner
|
PurchaseCommon Stock, par value $0.001 per share | 372 | $8.08 | $3,006.91 |
DisclosureSEC source: 0001493152-22-026144 · ownership.xml · nonDerivative · entry 4 Opaleye Management Inc. · CIK 0001595855 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Managed Account Disclosed balance after: 121,247 F3 · price: This transaction was executed in multiple trades at prices ranging from $8.0786 to $8.085; the price reported above reflects the weighted average purchase price. The reporting person undertakes to provide upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased. F2 · ownership.nature: Securities owned by a separately managed account (the "Managed Account"). As the portfolio manager of the Managed Account, Opaleye may be deemed to beneficially own the securities owned directly by the Managed Account. Read SEC document |
| September 16, 2022 Filed Sep 16, 2022 21:47 UTC |
Opaleye Management Inc.10% owner
|
PurchaseCommon Stock, par value $0.001 per share | 2,000 | $8.08 | $16,166.20 |
DisclosureSEC source: 0001493152-22-026144 · ownership.xml · nonDerivative · entry 3 Opaleye Management Inc. · CIK 0001595855 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Opaleye, L.P. Disclosed balance after: 1,890,500 F3 · price: This transaction was executed in multiple trades at prices ranging from $8.0786 to $8.085; the price reported above reflects the weighted average purchase price. The reporting person undertakes to provide upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased. F1 · ownership.nature: Represents securities owned directly by Opaleye, L.P. (the "Fund"). As the investment manager of the Fund, Opaleye Management Inc. may be deemed to beneficially own the securities owned directly by the Fund. Read SEC document |
| September 15, 2022 Filed Sep 16, 2022 21:47 UTC |
Opaleye Management Inc.10% owner
|
PurchaseCommon Stock, par value $0.001 per share | 658 | $8.10 | $5,329.80 |
DisclosureSEC source: 0001493152-22-026144 · ownership.xml · nonDerivative · entry 2 Opaleye Management Inc. · CIK 0001595855 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Managed Account Disclosed balance after: 120,875 F2 · ownership.nature: Securities owned by a separately managed account (the "Managed Account"). As the portfolio manager of the Managed Account, Opaleye may be deemed to beneficially own the securities owned directly by the Managed Account. Read SEC document |
| September 15, 2022 Filed Sep 16, 2022 21:47 UTC |
Opaleye Management Inc.10% owner
|
PurchaseCommon Stock, par value $0.001 per share | 3,500 | $8.10 | $28,350.00 |
DisclosureSEC source: 0001493152-22-026144 · ownership.xml · nonDerivative · entry 1 Opaleye Management Inc. · CIK 0001595855 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Opaleye, L.P. Disclosed balance after: 1,888,500 F1 · ownership.nature: Represents securities owned directly by Opaleye, L.P. (the "Fund"). As the investment manager of the Fund, Opaleye Management Inc. may be deemed to beneficially own the securities owned directly by the Fund. Read SEC document |
| August 17, 2022 Filed Aug 19, 2022 16:07 UTC |
EW HEALTHCARE PARTNERS FUND 2, L.P.See footnote 2
EW HEALTHCARE PARTNERS FUND 2-A, L.P.10% owner · See footnote 2
|
PurchaseCommon Stock, par value $0.001 per share | 500,000 | $8.00 | $4,000,000.00 |
DisclosureSEC source: 0000899243-22-029273 · doc4.xml · nonDerivative · entry 1 EW HEALTHCARE PARTNERS FUND 2, L.P. · CIK 0001746777 · See footnote 2 EW HEALTHCARE PARTNERS FUND 2-A, L.P. · CIK 0001746779 · 10% owner · See footnote 2 EW Healthcare Partners Fund 2 GP, L.P. · CIK 0001793943 · 10% owner EW Healthcare Partners Fund 2-UGP, LLC · CIK 0001793948 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnotes Disclosed balance after: 4,105,709 F1 · ownership.nature: The share total shown above is the aggregate amount of shares purchased by EW Healthcare Partners Fund 2, L.P. ("Fund 2") and EW Healthcare Partners Fund 2-A, L.P. ("Fund 2-A") on the date set forth above. Fund 2 purchased 196,483 shares of the amount shown above and Fund 2-A purchased 303,517 shares of the amount shown above. Fund 2 now holds a total of 1,630,994 shares and Fund 2-A now holds a total of 2,474,715 shares of the Issuer. F2 · ownership.nature: EW Healthcare Partners Fund 2 GP, L.P. (the "EW Funds GP"), is the general partner of each of EW Healthcare Partners Fund 2, L.P . ("Fund 2") and EW Healthcare Partners Fund 2-A, L.P. (''EW Fund 2-A" and together with EW Fund 2, the ''EW Funds"). EW Healthcare Partners Fund 2- UGP, LLC (the "General Partner") is the general partner of EW Funds GP. The General Partner holds sole voting and dispositive power over the shares held by each of the EW Funds (the "Shares''). The managers of the General Partner are Martin P. Sutter, Ron Eastman, Scott Barry and Petri Vainio (collectively, the ''Managers'') and may exercise voting and investment control over the Shares only by majority action of the Managers. Each individual Manager, the EW Funds GP and the General Partner disclaims ownership over the Shares except to the extent of his or its respective pecuniary interest therein. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.